Fig. 3From: Effect of bevacizumab combined with chemotherapy on SDF-1 and CXCR4 in epithelial ovarian cancer and its prognosisExpression of SDF-1 in group A and group B. A Expression level of SDF-1 in group A and group B (P>0.05); B Expression of CXCR4 increased with the illness of group A patients in stages II, III, and IV, and the relative expression of SDF-1 increased. C Spearman correlation analysis showed that the relative expression of SDF-1 was positively correlated with the stage of epithelial ovarian cancer (P<0.001)Back to article page